Halozyme Therapeutics Inc (NASDAQ:HALO)

15.89
Delayed Data
As of Apr 20
 +0.59 / +3.86%
Today’s Change
6.88
Today|||52-Week Range
16.55
+64.66%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Engler Robert L
Director
Sale5/15/2014126,700$7.56$957.9K+107.44%
Patton John Stuart
Director
Sale8/19/201475,000$9.96$747.0K+58.58%
Engler Robert L
Director
Buy5/15/2014150,000$4.10$615.0K+107.44%
Kelley Kenneth J
Director
Sale3/05/201540,000$15.33$613.2K+3.25%
Torley Helen I
President & Chief Executive Officer
Buy9/16/201450,000$8.92$446.0K+75.77%
Engler Robert L
Director
Sale8/14/201435,000$9.96$348.6K+59.38%
Ramsay David A
Chief Financial Officer & Vice President
Buy9/16/201425,000$8.90$222.5K+75.77%
Engler Robert L
Director
Buy8/14/201475,000$2.05$153.8K+59.38%
Patton John Stuart
Director
Buy8/19/201475,000$2.05$153.8K+58.58%
Torley Helen I
President & Chief Executive Officer
Sale1/06/201511,919$10.06$119.9K+57.95%
Page of 3

To view my watchlist

Not a member yet?

Sign up now for a free account